Center-Authored Papers

Export 2 results:
  • RTF
  • Tagged
  • XML
  • BibTex
  • Author
  • Keyword
  • Title
  • Type  (Asc)
  • Year
Filters: Author is Akerley, Wallace L  [Clear All Filters]
Journal Article
Margolin KA, Moon J, Flaherty LE, Lao CD, Akerley WL, Othus M, Sosman JA, Kirkwood JM, Sondak VK.  2012.  Randomized Phase II Trial of Sorafenib with Temsirolimus or Tipifarnib in Untreated Metastatic Melanoma (SWOG S0438).. Clinical cancer research : an official journal of the American Association for Cancer Research. 18(4):1129-1137. Abstract
  • RTF
  • Tagged
  • XML
  • BibTex
  • Google Scholar
  • PubMed
Lara PN, Moon J, Hesketh PJ, Redman MW, Williamson SK, Akerley WL, Hirsch FR, Mack PC, Gandara DR.  2015.  SWOG S0709: Randomized Phase II Trial of Erlotinib Versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
  • RTF
  • Tagged
  • XML
  • BibTex
  • Google Scholar
  • PubMed
  • Website Support/Questions?
  • SR Quick Reference
  • Fred Hutch Directory
  • SR Home

 

Doing Business with Arnold Library

Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org

More About Arnold Library

  • Information for Grant Writers
  • Arnold Library News

 

 

OFF-CAMPUS LOGIN

 

Quick Links

  • ILLiad/ILL Form
  • Journals List
  • Ovid - Medline
  • Web of Science
  • Pubmed
  • Libguides
  • Library Catalog
  • Researcher Profiles
  • Library Affiliations & Memberships
  • Fred Hutch Papers (Intranet)

 

Find us on FacebookFollow us on TwitterVisit our YouTube Channel

 

  • Fred Hutch Home
  • SR HOME
  • CENTERNET
  • LABS
  • LIBRARY HOME
Fred Hutchinson Cancer Research Center
Shared Resources
  • Core Facilities
  • Services
  • Data Analysis
  • About

Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy